Tabula Rasa HealthCare Performance
| TRHCDelisted Stock | USD 8.16 0.62 7.06% |
The entity has a beta of -0.5, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Tabula Rasa are expected to decrease at a much lower rate. During the bear market, Tabula Rasa is likely to outperform the market. Tabula Rasa HealthCare right now has a risk of 0.0%. Please validate Tabula Rasa downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Tabula Rasa will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Tabula Rasa HealthCare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, Tabula Rasa is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 15.7 M | |
| Total Cashflows From Investing Activities | 91.3 M |
Tabula |
Tabula Rasa Relative Risk vs. Return Landscape
If you would invest 816.00 in Tabula Rasa HealthCare on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Tabula Rasa HealthCare or generate 0.0% return on investment over 90 days. Tabula Rasa HealthCare is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Tabula, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tabula Rasa Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tabula Rasa's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tabula Rasa HealthCare, and traders can use it to determine the average amount a Tabula Rasa's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TRHC |
Based on monthly moving average Tabula Rasa is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tabula Rasa by adding Tabula Rasa to a well-diversified portfolio.
Tabula Rasa Fundamentals Growth
Tabula Stock prices reflect investors' perceptions of the future prospects and financial health of Tabula Rasa, and Tabula Rasa fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tabula Stock performance.
| Return On Equity | -5.55 | |||
| Return On Asset | -0.0598 | |||
| Profit Margin | (0.28) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 548.09 M | |||
| Shares Outstanding | 27.05 M | |||
| Price To Earning | 67.61 X | |||
| Price To Book | 3.69 X | |||
| Price To Sales | 0.34 X | |||
| Revenue | 299.52 M | |||
| EBITDA | (24.64 M) | |||
| Cash And Equivalents | 26.52 M | |||
| Cash Per Share | 1.11 X | |||
| Total Debt | 336.13 M | |||
| Book Value Per Share | (3.05) X | |||
| Cash Flow From Operations | 7.36 M | |||
| Earnings Per Share | (2.46) X | |||
| Total Asset | 384.15 M | |||
| Retained Earnings | (407.86 M) | |||
| Current Asset | 12.13 M | |||
| Current Liabilities | 51.57 M | |||
About Tabula Rasa Performance
By analyzing Tabula Rasa's fundamental ratios, stakeholders can gain valuable insights into Tabula Rasa's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tabula Rasa has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tabula Rasa has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey. Tabula Rasa operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1602 people.Things to note about Tabula Rasa HealthCare performance evaluation
Checking the ongoing alerts about Tabula Rasa for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tabula Rasa HealthCare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tabula Rasa is not yet fully synchronised with the market data | |
| Tabula Rasa has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 299.52 M. Net Loss for the year was (147.51 M) with profit before overhead, payroll, taxes, and interest of 66.91 M. | |
| About 71.0% of the company shares are owned by institutional investors |
- Analyzing Tabula Rasa's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tabula Rasa's stock is overvalued or undervalued compared to its peers.
- Examining Tabula Rasa's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tabula Rasa's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tabula Rasa's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tabula Rasa's stock. These opinions can provide insight into Tabula Rasa's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Tabula Stock
If you are still planning to invest in Tabula Rasa HealthCare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tabula Rasa's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |